BioCentury | Sep 24, 2001
Finance

Ebb & Flow

...$60.5-$71.5 million through the sale of 5.5 million shares at $11-$13 through Chase H&Q and Warburg Dillon Read...
BioCentury | Sep 19, 2001
Financial News

NetGenics withdraws IPO

...$60.5-$71.5 million through the sale of 5.5 million shares at $11-$13 through Chase H&Q and Warburg Dillon Read...
BioCentury | Oct 12, 2000
Financial News

DrugAbuse withdraws IPO

...on Wednesday cut the price again to $8-$9. The deal was to be underwritten by Warburg Dillon Read...
BioCentury | Oct 11, 2000
Financial News

DrugAbuse amends IPO

...to $9-$11 on Oct. 6. The deal, which has a 600,000-share overallotment, is underwritten by Warburg Dillon Read...
BioCentury | Oct 3, 2000
Financial News

Ciphergen shoe sold

...$101.2 million the total raised in the offering, underwritten by SG Cowen; ING Barings; and Warburg Dillon Read...
BioCentury | Sep 29, 2000
Financial News

Ciphergen raises $88 million in IPO

...sold 5.5 million shares at $16 in an IPO. Underwriters SG Cowen, ING Barings and Warburg Dillon Read...
BioCentury | Sep 1, 2000
Financial News

Aclara announces early release of lock-up

...45 days following the original lock-up expiration date on Sept. 16. Deutsche Banc Alex. Brown; Warburg Dillon Read...
BioCentury | Aug 28, 2000
Finance

Despite pullback, Germany looks robust

...to $69 million, also added PaineWebber and ABN-AMRO to the syndicate, and dropped Robertson, Stephens. Warburg Dillon Read...
BioCentury | Aug 24, 2000
Financial News

DrugAbuse to try IPO market again

...refiled to raise $48-$56 million through the sale of 4 million shares at $12-$14 through Warburg Dillon Read...
BioCentury | Aug 14, 2000
Finance

Some warning signs

...$15 price would value the company at $357.6 million. Kosan also shuffled its syndicate, removing Warburg Dillon Read...
Items per page:
1 - 10 of 117
BioCentury | Sep 24, 2001
Finance

Ebb & Flow

...$60.5-$71.5 million through the sale of 5.5 million shares at $11-$13 through Chase H&Q and Warburg Dillon Read...
BioCentury | Sep 19, 2001
Financial News

NetGenics withdraws IPO

...$60.5-$71.5 million through the sale of 5.5 million shares at $11-$13 through Chase H&Q and Warburg Dillon Read...
BioCentury | Oct 12, 2000
Financial News

DrugAbuse withdraws IPO

...on Wednesday cut the price again to $8-$9. The deal was to be underwritten by Warburg Dillon Read...
BioCentury | Oct 11, 2000
Financial News

DrugAbuse amends IPO

...to $9-$11 on Oct. 6. The deal, which has a 600,000-share overallotment, is underwritten by Warburg Dillon Read...
BioCentury | Oct 3, 2000
Financial News

Ciphergen shoe sold

...$101.2 million the total raised in the offering, underwritten by SG Cowen; ING Barings; and Warburg Dillon Read...
BioCentury | Sep 29, 2000
Financial News

Ciphergen raises $88 million in IPO

...sold 5.5 million shares at $16 in an IPO. Underwriters SG Cowen, ING Barings and Warburg Dillon Read...
BioCentury | Sep 1, 2000
Financial News

Aclara announces early release of lock-up

...45 days following the original lock-up expiration date on Sept. 16. Deutsche Banc Alex. Brown; Warburg Dillon Read...
BioCentury | Aug 28, 2000
Finance

Despite pullback, Germany looks robust

...to $69 million, also added PaineWebber and ABN-AMRO to the syndicate, and dropped Robertson, Stephens. Warburg Dillon Read...
BioCentury | Aug 24, 2000
Financial News

DrugAbuse to try IPO market again

...refiled to raise $48-$56 million through the sale of 4 million shares at $12-$14 through Warburg Dillon Read...
BioCentury | Aug 14, 2000
Finance

Some warning signs

...$15 price would value the company at $357.6 million. Kosan also shuffled its syndicate, removing Warburg Dillon Read...
Items per page:
1 - 10 of 117